Thiopurine Methyltransferase Polymorphisms Evaluation
NCT00166647 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2013-01-11
Summary
The purpose of the study is to determine the frequency of allelic variants in TPMT in the Hispanic population and to compare the frequency in the Hispanic population with the Caucasian Population.
Conditions
Interventions
- PROCEDURE
-
Blood Sampling
Sponsors & Collaborators
-
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
lead NIH
Eligibility
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-02-29
Countries
- United States
Study Locations
More Related Trials
-
Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma
NCT00991991 ·Status: TERMINATED
-
Ascertainment of Peripheral Blood or Saliva Samples for Genetic Epidemiology Studies of Familial Cancers
NCT00579163 ·Status: ACTIVE_NOT_RECRUITING
-
Malignant Hyperthermia Registry and Genetic Testing
NCT02964481 ·Status: TERMINATED
-
Prospective Registry of Multiplex Testing (PROMPT)
NCT02665195 ·Status: ACTIVE_NOT_RECRUITING
-
Universal- Versus Guidelines-Directed Genetic Testing for Germline Pathogenic Variants Utilizing a Multi-Gene Panel for Inherited Cancers in Non-Western Society.
NCT04920513 ·Status: COMPLETED
-
Familial Investigations of Childhood Cancer Predisposition
NCT03050268 ·Status: RECRUITING
-
Thymidylate Synthase Polymorphisms as a Predictor of Toxicity to Capecitabine Chemotherapy in Colon Cancer Treatment
NCT00126867 ·Status: TERMINATED
-
Biomarker Monitoring in TP53 Mutation Carriers
NCT02289326 ·Status: COMPLETED
-
Genetic Variants and Chemotherapy-induced Abnormal Thermal Sensation
NCT03252834 ·Status: TERMINATED
-
An Open Label Navigational Investigation of Molecular Profile-Related Evidence Determining Individualized Cancer Therapy for Patients With Incurable Hematologic Malignancies (I-PREDICT Heme)
NCT03955276 ·Status: TERMINATED
-
Implementation of the Families Accelerating Cascade Testing Toolkit (FACTT) for Hereditary Breast and Ovarian Cancer and Lynch Syndrome
NCT04508764 ·Status: TERMINATED ·Phase: NA
-
Genetic Evaluation of Families With Endocrine Cancers
NCT01794676 ·Status: COMPLETED
-
Definition of Mutational Profile of Papillary Thyroid Tumors by Mass-ARRAY
NCT05766098 ·Status: RECRUITING
-
Cancer Genetic Testing in Ethnic Populations
NCT04475640 ·Status: RECRUITING ·Phase: NA
-
Hereditary Risk Factors for Thyroid Cancer
NCT02747888 ·Status: RECRUITING ·Phase: NA
-
Molecular Genetic Studies of Childhood Brain Tumors and Blood Samples
NCT01650922 ·Status: COMPLETED
-
CIRculating Cell-free nUcLeic Acids in Cancer Therapy Monitoring -01
NCT05871593 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
A Gene Hunting Study for Familial Papillary Thyroid Cancer
NCT02776969 ·Status: ACTIVE_NOT_RECRUITING
-
Molecular Testing of Cancer by Integrated Genomic, Transcriptomic, and Proteomic Analysis
NCT02213822 ·Status: UNKNOWN
-
The Expression of PTEN Protein and mRNA in Malignant Cells of Chronic Myelomonocytic Leukemia
NCT01010256 ·Status: TERMINATED
-
Epigenetic and Metabolomic Changes in Childhood Cancer Survivors
NCT03866707 ·Status: TERMINATED
-
Analysis of Tumors From Patients With Inherited Cancers Having Had Two Surgeries (Primary + Recurrent, or 2 Separate Types of Cancer)
NCT01167842 ·Status: COMPLETED
-
Molecular Markers and Genetic Markers in Patients Undergoing Radiation Therapy for Cancer
NCT00899808 ·Status: WITHDRAWN
-
Molecular Markers in Thyroid Cancer
NCT00598364 ·Status: COMPLETED
-
Evaluating a Pharmacogenetic Testing Panel in Patients Suspected to be at Increased Risk for Pharmacogenetics-related AEs While Receiving Fluoropyrimidine or Irinotecan Therapy
NCT05583422 ·Status: COMPLETED